Osimertinib plus platinum–pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study
2021 · ESMO Open · 63 citations
https://doi.org/10.1016/j.esmoop.2021.100271